Cystic fibrosis, and following pancreatectomy, gastrectomy, chronic pancreatitis or pancreatic cancer obstructing outflow from the pancreas.

Brand: Creon, Nutrizym, Pancrease, Pancrex  (10,000, 25,000, 40,000)

Treatment to be initiated by Specialist, and transferred to Primary Care once treatment established to be tolerated and efficacious, please note in Primary Care Creon is first line, patients may be discharged from secondary care on an alternative brand for this indication.

NHS South Yorkshire ICB - Advice to primary care clinicians managing Pancreatic Enzyme Replacement Therapy (PERT) Click here